Unlock 30% off global market reports with code ONLINE30 – get insights on tariff changes, macro trends, and global economic shifts.
What is the projected value of the airlift bioreactors market by 2029?
The airlift bioreactors market size has grown rapidly in recent years. It will grow from $3.95 billion in 2024 to $4.38 billion in 2025 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to increased demand for single-use bioreactors, an increased number of clinical and preclinical trials performed, an increased focus on bioprocessing efficiency, increased demand from contract research organizations (CROs) and contract development and manufacturing organizations (CMOs), and government support and regulations.
The airlift bioreactors market size is expected to see rapid growth in the next few years. It will grow to $6.5 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to the growing output of various research and development activities for biochemicals, growing investments in healthcare, economic growth and development, growing awareness of the benefits of airlift bioreactors, and rising demand for customized and personalized medicines. Major trends in the forecast period include the emergence of new players, the use of airlift bioreactors in vaccine production, a growing focus on sustainability, demand for high-density cell culture, and a growing focus on regulatory compliance.
Download Your Free Sample PDF:
How are technological advancements fueling growth in the airlift bioreactors market?
The rising demand for biopharmaceutical products is expected to propel the growth of the airlift bioreactors market going forward. Biopharmaceutical products are medicinal products derived from living organisms or produced using biotechnological processes, including recombinant DNA technology, cell cultures, and monoclonal antibodies. The demand for biopharmaceutical products is increasing due to cell culture technologies, an increase in chronic diseases, the incidence of age-related diseases, innovations in bioprocessing, and advancements in genomics. Airlift bioreactors are highly beneficial in developing biopharmaceutical products due to their unique design and operational advantages, which are used in producing therapeutic proteins, monoclonal antibodies, and vaccines. For instance, in August 2023, according to a report by the Alliance for Regenerative Medicine, a US-based non-profit organization, there were 2,760 cell, gene, and tissue-engineering therapeutic developers worldwide in the first quarter of 2023, up 101% since 1,369 in the first quarter 2022. Therefore, rising demand for biopharmaceutical products is driving the growth of the airlift bioreactors market.
Which segment currently leads the airlift bioreactors market in terms of revenue share?
The airlift bioreactors market covered in this report is segmented –
1) By Product: Internal Airlift Loop Bioreactor, External Airlift loop Bioreactor
2) By Capacity: 5 Liters, 7 Liters, 10 Liters, 30 Liters
3) By Usage: Single-Use Or Disposal, Reusable
4) By Production Scale: Laboratory Scale, Pilot-Scale, Large Scale
5) By End-User: Biopharmaceutical Companies, Contract Research Organizations (CROs) Or Contract Development And Manufacturing Organizations (CDMOs), Research And Development Companies
Subsegments:
1) By Internal Airlift Loop Bioreactor: Circulating Bioreactor, Non-Circulating Bioreactor
2) By External Airlift Loop Bioreactor: Single-Stage External Airlift Bioreactor, Multi-Stage External Airlift Bioreactor
View The Full Market Report:
What evolving trends are creating new opportunities in the airlift bioreactors market?
Major companies operating in the airlift bioreactor market are focusing on advancing airlift technology in single-use bioreactors to enhance scalability, improve operational flexibility, and meet the growing demand for efficient and cost-effective bioprocessing solutions. Airlift technology in single-use bioreactors involves using a gas, typically air or oxygen, to circulate and mix the culture broth without mechanical agitation. This method leverages the differences in density between the gas-sparged (riser) and non-gas-sparged (downcomer) regions to create a natural circulation loop. For instance, in March 2022, Cellexus, a UK-based biotechnology company, introduced airlift single-use disposable bioreactor systems. This innovative bioreactor airlift technology replaces mechanical mixing with bubble-driven circulation, ensuring optimal aeration and promoting rapid cell growth by efficiently moving cells and nutrients. This system has minimal mechanical shear forces and operates without impellers.
Who are the top competitors in the global airlift bioreactors market?
Major companies operating in the airlift bioreactors market are Lonza Group AG, Sartorius AG, Cytiva, Zeta Global Corp., Shanghai Ritai Medicine Equipment Project Co. Ltd., Applikon Biotechnology, Kuhner Shaker Inc, Tecnal, bionet, Bailun Biotechnology Co.Ltd, ProAnalytics LLC, IVEN Pharmatech, Solida Biotech, LABOAO, Cellexus, Electrolab Biotech Ltd, Shree Biocare Solutions Pvt Ltd, BioReactor Sciences, Lab1st Scientific, Atlas Scientific, Cedarstone Industry, Belach Bioteknik AB, Biojenik Engineering, Vögtlin Instruments GmbH, OmniBRx Biotechnologies Pvt Ltd
What regional dynamics are shaping the future of the global airlift bioreactors market?
North America was the largest region in the airlift bioreactor market in 2023. The regions covered in the airlift bioreactors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Airlift Bioreactors Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
Need Customized Data On Airlift Bioreactors Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you're entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Comments
Post a Comment